Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
Duchenne muscular dystrophy (DMD) is a genetic disease affecting about one in every 3,500 boys. This X-linked pathology is due to the absence of dystrophin in muscle fibers. This lack of dystrophin leads to the progressive muscle degeneration that is often responsible for the death of the DMD patien...
Những tác giả chính: | Pichavant, C, Aartsma-Rus, A, Clemens, P, Davies, K, Dickson, G, Takeda, S, Wilton, S, Wolff, J, Wooddell, C, Xiao, X, Tremblay, J |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2011
|
Những quyển sách tương tự
-
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD.
Bằng: Pichavant, C, et al.
Được phát hành: (2011) -
Utrophin upregulation in DMD therapy: current status and new tools for the future
Bằng: Fairclough, R, et al.
Được phát hành: (2011) -
DMD antisense oligonucleotide mediated exon skipping efficiency correlates with flanking intron retention time and target position within the exon
Bằng: Remko Goossens, et al.
Được phát hành: (2023-12-01) -
BMP antagonists enhance myogenic differentiation and ameliorate the dystrophic phenotype in a DMD mouse model
Bằng: SongTing Shi, et al.
Được phát hành: (2011-02-01) -
DMD and West syndrome
Bằng: Cardas, R, et al.
Được phát hành: (2017)